Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
An Innovative Solution for Confocal Super Resolution
Wednesday, October 01, 2014
With the new Olympus FV-OSR software, the FluoView FV1200 is transformed into a powerful system for confocal Super Resolution microscopy.

New Mosaic 6.0 Makes Sample Management More Intuitive and Cost-effective
Tuesday, September 30, 2014
Latest version of Titian’s Mosaic software drives major increase in sample management efficiency.

Bioo Scientific Improves Sensitivity and Reliability of Tetracycline Detection
Tuesday, September 30, 2014
New MaxSignal® Tetracycline ELISA Kit with ready-to-use standards.

A New Solid-State Platform for High-Throughput ChIP
Thursday, September 25, 2014
Porvair’s new technical article provides an introduction to Chromatrap® 96.

Mobidiag Announces CE-IVD Marking of Amplidiag™ Bacterial GE
Thursday, September 25, 2014
Test optimizes screening of gastroenteritis-causing bacteria directly from stool samples.

Complete, Automated ASTM D2983 Sample Conditioning and Testing
Tuesday, September 16, 2014
The first fully automated Thermoelectric Sample Conditioner (TESC) System from CANNON.

Global OEM Strategy with a Wealth of Expertise and Experience
Tuesday, September 16, 2014
Company will be participating in the CPhl Worldwide pharmaceutical trade fair in Paris.

Rapid & Simple SPE Methods Development
Tuesday, September 16, 2014
The Development Microlute™ enables simple and rapid screening to achieve your sample preparation objectives.

Artel Expands Software Development and Support Team
Thursday, September 11, 2014
Greg Fischer joins Company as software project manager.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2578
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv